Feb. 4, 2025 — Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice. The ...

RNA-based therapeutics have rapidly emerged over the past decade, offering a new class of medicines that differ significantly from conventional drugs. These therapies can be programmed to target or ...

Precision BioSciences, Inc. (NASDAQ:DTIL) revealed initial results from the first administration of PBGENE-HBV in cohort 1, ...

Nanoparticle characterization is vital for mRNA vaccine efficacy, ensuring safety and regulatory compliance in the ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...

(Reuters) - President Donald Trump has moved to dramatically shrink the size of the federal workforce and mass terminations have already begun at several U.S. government agencies. But a tangled ...

Home > Press release: Research Training Group for the further ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and full year ended December 31, 2024, and provided ...

Encapsulation materials exhibiting promising properties with silicon PV, including a thermoplastic polyolefin encapsulant, were applied under different lamination conditions to investigate the impact ...

Photo shows New Year's Weather: Dark grey storm clouds over a green forested area, with a rain storm on the horizon.